Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (HTS, Omics Technologies) - Global Forecast to 2025

The global human microbiome market is estimated to reach USD 899.1 Million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025). Rising aging population, increasing incidences of lifestyle diseases, gradual demand for efficient and safe medication with no side effects, and treatment of diseases having a limited success rate are driving the growth of the human microbiome market. The human microbiome market is an emerging market with abundant opportunities and is expected to flourish within five to seven years owing to a number of products currently under the clinical trial phase. In this report, the global human microbiome market is divided into three major segments namely, application, disease, and product.

The products segment is further classified into: probiotics, prebiotics, food, medical foods, devices, drugs and other probiotic supplements. The probiotics segment is expected to account for the largest share in the human microbiome market. The large share of this segment can be attributed to the growing adoption of probiotic products.

The disease segment is also further categorized into: obesity, diabetes, autoimmune disorder, cancer, acute diarrhea, mental disorder and other diseases (cardiovascular, metabolic syndrome (elevated blood lipids, high bp, and liver diseases), drug metabolism, and atopic dermatitis). Acute diarrhea is expected to account for the largest share of the human microbiome market. Factors such as rising prevalence of communicable diseases, growing awareness among patients regarding the use of microbiome-based products, and technological advancements will stimulate the growth of this segment in the human microbiome disease market.

The factors restraining the human microbiome market include lack of comprehensive research to assist in market pull, lack of awareness among the population regarding the efficient usage and effect of prebiotics and probiotics, and impending government regulations on probiotics and prebiotics.

Europe is expected to command as a resourceful market with the largest share in the human microbiome market and expected to grow within the coming years. This is due to Europe’s aging population size and the increasing lifestyle diseases, followed by the increasing need to stay fit and have a healthy lifestyle has leveraged the use of prebiotics and probiotics. APAC accounted for the second-largest market share and will be the main focus of the market in the coming five years that will register high-growth rates for all the segments.

The key players in the human microbiome market are Enterome Bioscience (France), Yakult (Japan), DuPont (U.S.), Metabiomics Corporation (U.S.), and ViThera Pharmaceuticals (U.S.)

Scope of the Report:

The research report categorizes the human microbiome market into the following segments and subsegments:

Human Microbiome Market, by Product

• Probiotics
• Prebiotics
• Food
• Medical Foods
• Devices
• Drugs
• Other Probiotic supplements

Human Microbiome Market, by Application

• Therapeutics
• Diagnostics

Human Microbiome Market, by Disease

• Obesity
• Diabetes
• Autoimmune Disorder
• Cancer
• Acute Diarrhea
• Mental Disorder
• Other (Cardiovascular, Metabolic Syndrome (Elevated Blood Lipids, High Bp, and Liver Diseases), Drug Metabolism, and Atopic Dermatitis)

Human Microbiome Research Spending Market, by Product

• Instruments
• Laboratory Instruments
• Analyzers
• Consumables
• Kits
• Reagents

Human Microbiome Research Spending Market, by Technology

• Omics Technology
• High-throughput Technology
• Cell Culture Technology
• Computational Tools

Global Human Microbiome Market, by Region

• North America
  • U.S.
  • Canada
• Asia-Pacific
• Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

• Product matrix which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

• Further breakdown of Europe and Asia-Pacific Human market into Japan, China, India, South Korea and other countries

Company Information

• Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Approach
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
           2.3.1 Key Data From Secondary Sources
           2.3.2 Key Data From Primary Sources
           2.3.3 Key Industry Insights
           2.3.4 Assumptions

3 Executive Summary (Page No. - 26)

4 Human Microbiome Market : Premium Insights (Page No. - 30)
    4.1 Market Overview
    4.2 Global Market, By Product (2022)
    4.3 Geographic Growth Opportunities
    4.4 Geographic Mix
    4.5 Developing vs Developed Regions
    4.6 Global Research Spending Market, By Technology

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increased Focus on Human Microbiome Therapy
                    5.2.1.2 Human Microbiome as New Validated Target for Drug Development
                    5.2.1.3 Human Microbiome for Early Disease Detection and Diagnosis
           5.2.2 Restraints
                    5.2.2.1 Lack of Expertise and Detailed Research
                    5.2.2.2 Barriers in Proving the Causal Link Between Dysbiosis and Disease
           5.2.3 Opportunities
                    5.2.3.1 Investigational New Drug (IND) Requirements for Fecal Microbiota
                    5.2.3.2 Increasing Collaborations Create Growth Opportunities
           5.2.4 Challenge
                    5.2.4.1 Government Regulations
           5.2.5 Burning Issues
                    5.2.5.1 Abundant Opportunities in the Human Microbiome Field and Tremendous Research Investments
                    5.2.5.2 Development of Human Microbiome Therapeutic Products
    5.3 Patents
    5.4 Funding

6 Human Microbiome Market, By Product (Page No. - 43)
    6.1 Introduction
    6.2 Probiotics
    6.3 Foods
    6.4 Prebiotics
    6.5 Medical Foods
    6.6 Diagnostic Devices
    6.7 Drugs
    6.8 Other Probiotic Supplements

7 Human Microbiome Market, By Application (Page No. - 52)
    7.1 Introduction
    7.2 Therapeutics
    7.3 Diagnostics

8 Human Microbiome Market, By Disease (Page No. - 56)
    8.1 Introduction
    8.2 Acute Diarrhea
    8.3 Obesity
    8.4 Diabetes
    8.5 Autoimmune Disorders
    8.6 Cancer
    8.7 Mental Disorders
    8.8 Other Diseases

9 Human Microbiome Research Spending Market, By Product (Page No. - 65)
    9.1 Introduction
    9.2 Instruments
           9.2.1 Laboratory Instruments
           9.2.2 Analyzers
    9.3 Consumables
           9.3.1 Kits
           9.3.2 Reagents

10 Human Microbiome Research Spending Market, By Technology (Page No. - 74)
     10.1 Introduction
     10.2 Cell Culture Technology
     10.3 High-Throughput Technology
     10.4 Omics Technology
     10.5 Computational Tools

11 Human Microbiome Market, By Region (Page No. - 80)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
     11.4 Asia-Pacific
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 107)
     12.1 Overview
     12.2 Competitive Situation and Trends
             12.2.1 Agreements, Partnerships, and Collaborations
             12.2.2 Expansions
             12.2.3 Product Launches and Approvals
             12.2.4 Other Developments

13 Company Profiles (Page No. - 112)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Enterome Bioscience
     13.2 E.I. Du Pont De Nemours and Company
     13.3 Merck & Co., Inc.
     13.4 Metabiomics Corporation
     13.5 Yakult Honsha Co., Ltd.
     13.6 Microbiome Therapeutics, LLC
     13.7 Osel, Inc.
     13.8 Second Genome, Inc.
     13.9 Vithera Pharmaceuticals
     13.10 Vedanta Biosciences, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 134)
     14.1 Insights From Industry Experts
     14.2 Discussion Guide
     14.3 Other Developments
     14.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.5 Introducing RT: Real-Time Market Intelligence
     14.6 Available Customizations
     14.7 Related Reports
     14.8 Author Details

List of Tables (91 Tables)

Table 1 Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 2 Market Size for Probiotics, By Region, 2022-2025 (USD Million)
Table 3 Market for Foods, By Region, 2022-2025 (USD Million)
Table 4 Human Microbiome Market Size for Prebiotics, By Region, 2022-2025 (USD Million)
Table 5 Market Size for Medical Foods, By Region, 2022-2025 (USD Million)
Table 6 Market Size for Diagnostic Devices, By Region, 2020–2025 (USD Million)
Table 7 Market Size for Drugs, By Region, 2022–2025 (USD Million)
Table 8 Human Microbiome Market Size for Other Probiotic Supplements, By Region, 2022-2025 (USD Million)
Table 9 Market Size, By Application, 2022–2025 (USD Million)
Table 10 Market Size for Therapeutic Applications, By Region, 2022–2025 (USD Million)
Table 11 Market Size for Diagnostic Applications, By Region, 2021–2025 (USD Million)
Table 12 Market Size, By Disease, 2022–2025 (USD Million)
Table 13 Human Microbiome Market Size for Acute Diarrhea, By Region, 2022–2025 (USD Million)
Table 14 Market Size for Obesity, By Region, 2021–2025 (USD Million)
Table 15 Market Size for Diabetes, By Region, 2022–2025 (USD Million)
Table 16 Market Size for Autoimmune Disorders, By Region, 2021–2025 (USD Million)
Table 17 Human Microbiome Market Size for Cancer, By Region, 2022–2025 (USD Million)
Table 18 Market Size for Mental Disorders, By Region, 2022–2025 (USD Million)
Table 19 Human Microbiome Market Size for Other Diseases, By Region, 2021–2025 (USD Million)
Table 20 Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 21 Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 22 Research Spending Market Size for Instruments, By Region, 2014–2021 (USD Million)
Table 23 North America: Research Spending Market Size for Instruments, By Country, 2014–2021 (USD Million)
Table 24 Human Microbiome Research Spending Market Size for Laboratory Instruments, By Region, 2014–2021 (USD Million)
Table 25 North America: Research Spending Market Size for Laboratory Instruments, By Country, 2014–2021 (USD Million)
Table 26 Human Microbiome Research Spending Market Size for Analyzers, By Region, 2014–2021 (USD Million)
Table 27 North America: Research Spending Market Size for Analyzers, By Country, 2014–2021 (USD Million)
Table 28 Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 29 Human Microbiome Research Spending Market Size for Consumables, By Region, 2014–2021 (USD Million)
Table 30 North America: Research Spending Market Size for Consumables, By Country, 2014–2021 (USD Million)
Table 31 Human Microbiome Research Spending Market Size for Kits, By Region, 2014–2021 (USD Million)
Table 32 North America: Research Spending Market Size for Kits, By Country, 2014–2021 (USD Million)
Table 33 Human Microbiome Research Spending Market Size for Reagents, By Region, 2014–2021 (USD Million)
Table 34 North America: Human Microbiome Research Spending Market Size for Reagents, By Country, 2014–2021 (USD Million)
Table 35 Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Human Microbiome Research Spending Market Size for Cell Culture Technology, By Region, 2014–2021 (USD Million)
Table 37 North America: Research Spending Market Size for Cell Culture Technology, By Country, 2014–2021 (USD Million)
Table 38 Human Microbiome Research Spending Market Size for High-Throughput Technology, By Region, 2014–2021 (USD Million)
Table 39 North America: Research Spending Market Size for High-Throughput Technology, By Country, 2014–2021 (USD Million)
Table 40 Human Microbiome Research Spending Market Size for Omics Technology, By Region, 2014–2021 (USD Million)
Table 41 North America: Research Spending Market Size for Omics Technology, By Country, 2014–2021 (USD Million)
Table 42 Human Microbiome Research Spending Market Size for Computational Tools, By Region, 2014–2021 (USD Million)
Table 43 North America: Human Microbiome Research Spending Market Size for Computational Tools, By Country, 2014–2021 (USD Million)
Table 44 Human Microbiome Market Size, By Region, 2022–2025 (USD Million)
Table 45 Human Microbiome Research Spending Market Size, By Region, 2014–2021 (USD Million)
Table 46 North America: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 47 North America: Market Size, By Application, 2022–2025 (USD Million)
Table 48 North America: Human Microbiome Market Size, By Disease, 2022–2025 (USD Million)
Table 49 North America: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 50 North America: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 51 North America: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 52 North America: Human Microbiome Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 53 U.S.: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 54 U.S.: Market Size, By Application, 2022–2025 (USD Million)
Table 55 U.S.: Human Microbiome Market Size, By Disease, 2022–2025 (USD Million)
Table 56 U.S.: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 57 U.S.: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 58 U.S.: Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 59 U.S.: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 60 Canada: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 61 Canada : Market Size, By Application, 2022–2025 (USD Million)
Table 62 Canada : Human Microbiome Market Size, By Disease, 2022–2025 (USD Million)
Table 63 Canada: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 64 Canada: Human Microbiome Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 65 Canada: Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 66 Canada: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 67 Europe: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 68 Europe: Market Size, By Application, 2022–2025 (USD Million)
Table 69 Europe: Human Microbiome Market Size, By Disease, 2022–2025 (USD Million)
Table 70 Europe: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 71 Europe: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 72 Europe: Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 73 Europe: Human Microbiome Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 74 Asia-Pacific: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 75 Asia-Pacific: Market Size, By Application, 2020–2025 (USD Million)
Table 76 Asia-Pacific: Human Microbiome Market Size, By Disease, 2022–2025 (USD Million)
Table 77 APAC: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million
Table 78 APAC: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 79 APAC: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 80 APAC: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 81 RoW: Human Microbiome Market Size, By Product, 2022–2025 (USD Million)
Table 82 RoW: Market Size, By Application, 2022–2025 (USD Million)
Table 83 RoW: Human Microbiome Market Size, By Disease, 2022–2025 (USD Million)
Table 84 RoW: Human Microbiome Research Spending Market Size, By Product, 2014–2021 (USD Million)
Table 85 RoW: Research Spending Market Size for Instruments, By Type, 2014–2021 (USD Million)
Table 86 RoW: Human Microbiome Research Spending Market Size for Consumables, By Type, 2014–2021 (USD Million)
Table 87 RoW: Research Spending Market Size, By Technology, 2014–2021 (USD Million)
Table 88 Agreements, Partnerships, and Collaborations, 2013–2016
Table 89 Expansions, 2013–2016
Table 90 Product Launches and Approvals, 2013–2016
Table 91 Other Developments, 2013–2016

List of Figures (30 Figures)

Figure 1 Human Microbiome: Market Segmentation
Figure 2 Human Microbiome Research Spending: Market Segmentation
Figure 3 Research Design
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 7 Probiotics Segment to Dominate the Human Microbiome Market During the Forecast Period
Figure 8 Consumables Segment to Witness the Highest Growth Rate in the Microbiome Research Spending Market From 2016 to 2021
Figure 9 Cell Culture Technologies to Dominate the Human Microbiome Research Spending Market in 2015
Figure 10 Geographical Snapshot of the Global Human Microbiome Market, 2022
Figure 11 Growing Prevalence of Lifestyle Diseases and Increasing Acceptance of Microbiome-Based Products are Major Growth Drivers
Figure 12 Probiotics Segment Dominated the Human Microbiome Market in 2022
Figure 13 North America Accounted for the Largest Share of the Human Microbiome Market in 2022-2025
Figure 14 North America to Grow at the Highest CAGR During the Forecast Period
Figure 15 Developed Regions to Grow at Higher CAGRs From 2022 to 2025
Figure 16 Cell Culture Technology Segment Dominated the Human Microbiome Research Spending Market in 2015
Figure 17 Human Microbiome Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Funds Provided for Microbiome Research By Various Medical Research Agencies
Figure 19 Probiotics Segment to Command the Largest Share of the Human Microbiome Product Market By 2025
Figure 20 The Therapeutics Segment to Command the Largest Share of the Human Microbiome Applications Market By 2025
Figure 21 Acute Diarrhea Expected to Be the Largest Disease Segment of the Human Microbiome Market in 2022
Figure 22 Geographic Snapshot (2022): North America Will Be the Fastest-Growing Region By 2022
Figure 23 North America to Grow at the Fastest Rate in the Human Microbiome Product Market From 2022 to 2025
Figure 24 Europe: Human Microbiome Market Snapshot
Figure 25 Companies Adopted Agreements, Collaborations, and Partnerships as the Key Growth Strategy Over the Last Three Years
Figure 26 Battle for Market Share: Agreements, Collaborations, and Partnerships are Key Growth Strategies for Market Players
Figure 27 Geographic Revenue Mix of Top 3 Market Players
Figure 28 E.I. Du Pont De Nemours and Company: Company Snapshot (2015)
Figure 29 Merck & Co., Inc.: Company Snapshot (2015)
Figure 30 Yakult Honsha Co., Ltd.: Company Snapshot (2016)

The human microbiome market is segmented into application, disease, product, and region while the human microbiome research spending market is broadly segmented into product and technology.

The market is expected to be valued as USD 506.5 Million in 2022 and is poised to grow at a CAGR of 21.1% within the forecast period of 2022–2025. Factors such as increased focus on human microbiome therapy, growing demand for human microbiomes as new validated targets for drug development, and the need for early disease detection and diagnosis are expected to drive the growth of the human microbiome market. However, government regulation and lack of detailed research may restrain the growth of this market to an extent.

On the basis of application, the market segmented into therapeutics and diagnostics. The therapeutics segment is expected to be the leading segment of the human microbiome applications market in 2022. This is due to the need for reliable, precise, and quicker detection of chronic lifestyle diseases and various other disorders.

On the basis of disease, the market is segmented into obesity, diabetes, autoimmune disorders, cancer, acute diarrhea, mental disorders, and other diseases. The acute diarrhea segment is expected to account for the largest share of the global human microbiome market in 2022. This is due to microbiome-based products being steadily used for diarrhea indications and increased used is expected to propel the market growth in the coming years.

On the basis of product, the market is segmented into probiotics, prebiotics, foods, medical foods, other supplements, devices, and drugs. The prebiotics market is expected to be the most dynamic product segment and witness significant growth over the next five years owing to the increasing number of chronic and lifestyle diseases.

The human microbiome research spending market, by product, is characterized into instruments and consumables. The instruments segment is further segmented into laboratory instruments and analyzers, while, the consumables segment is further bifurcated into kits and reagents. The consumables segment is estimated to be the fastest- growing segment by 2021, owing to the repeated purchases of consumables as compared to instruments.

The human microbiome research spending market, by technology, is divided into cell culture technology, high-throughput technology, omics technology, and computational tools. The cell culture technology is the most widely-used technology in microbiome research, and is expected to account for the largest share of the human microbiome research spending market in 2016. The large share of this segment can be attributed to its usage in the in vitro model to reproduce in vivo conditions and to study host-microbial community interactions.

The geographic analysis reveals that Europe will account for the largest share within the forecast period of 2022 to 2025, due to the high acceptance of probiotic and prebiotic products. North America is expected to be a profitable region for the human microbiome market and poised to grow at a healthy CAGR in the forecast period.

The key players in the market are Enterome Bioscience (France), Yakult Honsha Co., Ltd. (Japan), E. I. Du Pont de Nemours and Company (U.S.), Metabiomics Corporation (U.S.), ViThera Pharmaceuticals (U.S.), Second Genome, Inc. (U.S.), MicroBiome Therapeutics LLC (U.S.), Vedanta BioSciences, Inc. (U.S.), Osel, Inc. (U.S.), and Merck & Co, Inc. (U.S.)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst